COAG
COAG
US4234941031
Hemab Therapeutics Holdings, In
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Market & Enterprise Value
Market Cap
1.48B EUR
1.72B EUR
Enterprise Value
986.5M EUR
1.48B EUR
Valuation Multiples
Trailing P/E
--
--
Forward P/E
-12.46x
--
Price to Sales
--
--
Price to Book
3.25x
3.78x
EV/Revenue
--
--
EV/EBITDA
-11.35x
--
Price to FCF (P/FCF)
--
--
EV/FCF
--
--
FCF Yield
--
-4.24%
ende